130 related articles for article (PubMed ID: 15489130)
1. Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium- and long-chain triacylglycerols.
Christensen JØ; Schultz K; Mollgaard B; Kristensen HG; Mullertz A
Eur J Pharm Sci; 2004 Nov; 23(3):287-96. PubMed ID: 15489130
[TBL] [Abstract][Full Text] [Related]
2. A dynamic in vitro lipolysis model. II: Evaluation of the model.
Zangenberg NH; Müllertz A; Kristensen HG; Hovgaard L
Eur J Pharm Sci; 2001 Oct; 14(3):237-44. PubMed ID: 11576829
[TBL] [Abstract][Full Text] [Related]
3. Study of drug concentration effects on in vitro lipolysis kinetics in medium-chain triglycerides by considering oil viscosity and surface tension.
Arnold YE; Imanidis G; Kuentz M
Eur J Pharm Sci; 2011 Oct; 44(3):351-8. PubMed ID: 21884787
[TBL] [Abstract][Full Text] [Related]
4. How relevant are assembled equilibrium samples in understanding structure formation during lipid digestion?
Phan S; Salentinig S; Hawley A; Boyd BJ
Eur J Pharm Biopharm; 2015 Oct; 96():117-24. PubMed ID: 26212786
[TBL] [Abstract][Full Text] [Related]
5. A novel excipient, 1-perfluorohexyloctane shows limited utility for the oral delivery of poorly water-soluble drugs.
Holm R; Jørgensen EB; Harborg M; Larsen R; Holm P; Müllertz A; Jacobsen J
Eur J Pharm Sci; 2011 Mar; 42(4):416-22. PubMed ID: 21256961
[TBL] [Abstract][Full Text] [Related]
6. Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium.
Borkar N; Xia D; Holm R; Gan Y; Müllertz A; Yang M; Mu H
Eur J Pharm Sci; 2014 Jan; 51():204-10. PubMed ID: 24134899
[TBL] [Abstract][Full Text] [Related]
7. Structural development of self nano emulsifying drug delivery systems (SNEDDS) during in vitro lipid digestion monitored by small-angle X-ray scattering.
Fatouros DG; Deen GR; Arleth L; Bergenstahl B; Nielsen FS; Pedersen JS; Mullertz A
Pharm Res; 2007 Oct; 24(10):1844-53. PubMed ID: 17458683
[TBL] [Abstract][Full Text] [Related]
8. Silica-lipid hybrid microcapsules: influence of lipid and emulsifier type on in vitro performance.
Lim LH; Tan A; Simovic S; Prestidge CA
Int J Pharm; 2011 May; 409(1-2):297-306. PubMed ID: 21371543
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the effect of medium- vs. long-chain triglycerides on the in vitro solubilization of cholesterol and/or phytosterol into mixed micelles.
von Bonsdorff-Nikander A; Christiansen L; Huikko L; Lampi AM; Piironen V; Yliruusi J; Kaukonen AM
Lipids; 2005 Feb; 40(2):181-90. PubMed ID: 15884767
[TBL] [Abstract][Full Text] [Related]
10. The effect of administered dose of lipid-based formulations on the in vitro and in vivo performance of cinnarizine as a model poorly water-soluble drug.
Lee KW; Porter CJ; Boyd BJ
J Pharm Sci; 2013 Feb; 102(2):565-78. PubMed ID: 23242691
[TBL] [Abstract][Full Text] [Related]
11. Insights into intermediate phases of human intestinal fluids visualized by atomic force microscopy and cryo-transmission electron microscopy ex vivo.
Müllertz A; Fatouros DG; Smith JR; Vertzoni M; Reppas C
Mol Pharm; 2012 Feb; 9(2):237-47. PubMed ID: 22136289
[TBL] [Abstract][Full Text] [Related]
12. Chain length affects pancreatic lipase activity and the extent and pH-time profile of triglyceride lipolysis.
Benito-Gallo P; Franceschetto A; Wong JC; Marlow M; Zann V; Scholes P; Gershkovich P
Eur J Pharm Biopharm; 2015 Jun; 93():353-62. PubMed ID: 25936853
[TBL] [Abstract][Full Text] [Related]
13. In vitro-in vivo correlations of self-emulsifying drug delivery systems combining the dynamic lipolysis model and neuro-fuzzy networks.
Fatouros DG; Nielsen FS; Douroumis D; Hadjileontiadis LJ; Mullertz A
Eur J Pharm Biopharm; 2008 Aug; 69(3):887-98. PubMed ID: 18367386
[TBL] [Abstract][Full Text] [Related]
14. Modulating β-carotene bioaccessibility by controlling oil composition and concentration in edible nanoemulsions.
Salvia-Trujillo L; Qian C; Martín-Belloso O; McClements DJ
Food Chem; 2013 Aug; 139(1-4):878-84. PubMed ID: 23561185
[TBL] [Abstract][Full Text] [Related]
15. Safety evaluation of a medium- and long-chain triacylglycerol oil produced from medium-chain triacylglycerols and edible vegetable oil.
Matulka RA; Noguchi O; Nosaka N
Food Chem Toxicol; 2006 Sep; 44(9):1530-8. PubMed ID: 16753249
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides.
Grove M; Müllertz A; Nielsen JL; Pedersen GP
Eur J Pharm Sci; 2006 Jun; 28(3):233-42. PubMed ID: 16650738
[TBL] [Abstract][Full Text] [Related]
17. Improving Correlations Between Drug Solubilization and In Vitro Lipolysis by Monitoring the Phase Partitioning of Lipolytic Species for Lipid-Based Formulations.
Dening TJ; Joyce P; Prestidge CA
J Pharm Sci; 2019 Jan; 108(1):295-304. PubMed ID: 30257194
[TBL] [Abstract][Full Text] [Related]
18. Vitamin E bioaccessibility: influence of carrier oil type on digestion and release of emulsified α-tocopherol acetate.
Yang Y; McClements DJ
Food Chem; 2013 Nov; 141(1):473-81. PubMed ID: 23768382
[TBL] [Abstract][Full Text] [Related]
19. Using the polymer partitioning method to probe the thermodynamic activity of poorly water-soluble drugs solubilized in model lipid digestion products.
Boyd BJ; Porter CJ; Charman WN
J Pharm Sci; 2003 Jun; 92(6):1262-71. PubMed ID: 12761815
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo evaluations of the performance of an indirubin derivative, formulated in four different self-emulsifying drug delivery systems.
Heshmati N; Cheng X; Dapat E; Sassene P; Eisenbrand G; Fricker G; Müllertz A
J Pharm Pharmacol; 2014 Nov; 66(11):1567-75. PubMed ID: 24961657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
